Hillstream BioPharma Inc（THAR）美股招股说明书 S-1 （2022-01-05修订版）（英文版）（207页）.pdf

1、S-1/A 1 forms-1a.htm As filed with the Securities and Exchange Commission on January 5,2022 Registration Statement No.333-259821 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 Amendment No.4ToFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 HILLSTREAM BIOPHARMA,INC.

2、(Exact name of registrant as specified in its charter)Delaware 2834 84-2642541(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)1200 Route 22 East,Suite 2000Bridgewater,NJ 08807(908)955-3140(Addres

3、s,including zip code and telephone number,including area code of registrants principal executive offices)Randy MilbyChief Executive OfficerHillstream BioPharma,Inc.1200 Route 22 East,Suite 2000Bridgewater,NJ 08807(908)955-3140(Name,address,including zip code,and telephone number,including area code,

4、of agent for service)Copies to:Jeffrey J.Fessler,Esq.Nazia J.Khan,Esq.Sheppard,Mullin,Richter&Hampton LLP30 Rockefeller PlazaNew York,NY 10112-0015Tel.:(212)653-8700 Rob Condon,Esq.Dentons US LLP1221 Avenue of the AmericasNew York,NY 10020-1089Tel.:(212)768-6700 Approximate date of commencement of p

5、roposed sale to the public:As soon as practicable after the date this registration statement becomes effective.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule415 under the Securities Act of 1933 check the following box:If thi

6、s Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,pleasecheck the following box and list the Securities Act registration statement number of the earlier effective registration statement forthe same offering.If this Form is a post-effect